The Levonorgestrel Intrauterine System: Long-Term Contraception and Therapeutic Effects-Reference-Cited by-同舟云学术

The Levonorgestrel Intrauterine System: Long-Term Contraception and Therapeutic Effects

Published:2005-09 Issue:2 Volume:1 Page:171-182
ISSN:1745-5065
Container-title:Women's Health
language:en
Short-container-title:Womens Health (Lond Engl)

Author:

Sitruk-Ware Regine¹,Inki Pirjo²

Affiliation:

1. Population Council, 1230 York Avenue, New York 10021, USA, Tel.: +1 212 327 7045; Fax: +1 212 327 7678;

2. Schering Oy, PO Box 415 20101 Turku, Finland, Tel.: +358 405 501 519; Fax: +358 2 333 2648;

Abstract

The levonorgestrel intrauterine system (Mirena®) has been developed as a long-acting method of contraception. This medicated device, inserted into the uterus, delivers a small daily dose of a progestin, levonorgestrel, into the uterine cavity. It is one of the most effective methods of contraception and is approved in more than 100 countries for 5 years of use.

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.2217/17455057.1.2.171

Reference66 articles.

1. Levonorgestrel-Releasing Intrauterine Device

2. The Levonorgestrel Intrauterine System: A Clinical Perspective from the UK

3. Risks and Benefits, Advantages and Disadvantages of Levonorgestrel-Releasing Contraceptive Implants

4. Pharmacological profile of progestins

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial;Journal of Gynecologic Oncology;2024

2. Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities;Advanced Drug Delivery Reviews;2022-12

3. Effect of crosslinking on the physicochemical properties of polydimethylsiloxane-based levonorgestrel intrauterine systems;International Journal of Pharmaceutics;2021-11

4. The effect of a levonorgestrel-releasing intrauterine device on female sexual function;Journal of Obstetrics and Gynaecology;2020-06-05

5. A randomized controlled pilot study of ulipristal acetate for abnormal bleeding among women using the 52‐mg levonorgestrel intrauterine system;International Journal of Gynecology & Obstetrics;2019-12-11